Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Cambrex to Acquire Halo Pharma for $425 Million

July 23, 2018

The acquisition will place Cambrex into the finished dosage form CDMO market.

FDA Reveals Biosimilar Plan; Gottlieb Blasts Delays

July 19, 2018

In launching FDA’s Biosimilar Action Plan, Gottlieb takes innovator companies to task for delaying competitive biosimilar products.

Cross-Industry Expertise Can Promote Manufacturing Improvements

July 09, 2018

Report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve biopharma manufacturing efficiencies.

Selecting Primary Packaging for Parenterals

July 02, 2018

Traditional glass and polymeric materials compete for market share in primary packaging for parenteral drug products.

Testing Foreign Particulate Matter in Inhaled Products

July 02, 2018

The delivery device and drug form should be considered when choosing a test method for identifying and measuring particulates in inhaled drug products.

The Search for Next-Gen Expression Systems

July 02, 2018

Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.

Selecting Excipients for Controlled Release

July 02, 2018

With the right excipients, formulators can control when, where, and how an API is released.

Minakem Opens New High Containment Facility

June 25, 2018

Minakem’s facility in Belgium enhances capacity to scale production of highly potent ingredients for small to full GMP batches.

FDA Approves First Cannabidiol-based Drug

June 25, 2018

GW Research’s Epidiolex, which treats two forms of epilepsy, receives FDA’s approval; spurs FDA reminders about unapproved products.

Recipharm Acquires Respiratory Drug Site

June 14, 2018

Recipharm adds inhalation drug manufacturing capacity with the acquisition of Sanofi’s Holmes Chapel, UK site.